New Tysabri And Anti-JCV Antibody Stability Data Released
Biogen Idec and Elan Corporation, plc announced results from several studies of Tysabri(R) (natalizumab) that demonstrate its efficacy compared to other multiple sclerosis (MS) treatments, provide additional data supporting anti-JC virus (JCV) antibody status stability, and suggest better outcomes when progressive multifocal leukoencephalopathy (PML) is detected early. These data will be presented at the 65th Annual Meeting of the American Academy of Neurology (AAN) in San Diego.........Read More - http://www.ms-uk.org/index.cfm/tysabri
New Tysabri And Anti-JCV Antibody Stability Data Released
New Tysabri And Anti-JCV Antibody Stability Data Released
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1593 Views
-
Last post by frodo
-
- 0 Replies
- 1375 Views
-
Last post by frodo
-
- 0 Replies
- 1404 Views
-
Last post by Petr75
-
- 0 Replies
- 2363 Views
-
Last post by frodo
-
- 0 Replies
- 10701 Views
-
Last post by NHE
-
- 0 Replies
- 1972 Views
-
Last post by NHE
-
- 0 Replies
- 2485 Views
-
Last post by frodo
-
- 0 Replies
- 1528 Views
-
Last post by frodo
-
- 9 Replies
- 14245 Views
-
Last post by ElliotB